ENSC (STOCKS)
Ensysce Biosciences, Inc. Common Stock
$0.500000
+0.035500 (+7.64%)
Prev close: $0.464500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- D. Lynn Kirkpatrick
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.14M
- Employees
- 8
- P/E (TTM)
- -0.11
- P/B (TTM)
- 0.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.75 | $-1.29 | +0.5352 | +41.64% |
|
Sep 2025 (Q3)
|
$-1.29 | $-0.88 | -0.4077 | -46.21% |
|
Jun 2025 (Q2)
|
$-0.79 | $-1.20 | +0.4136 | +34.36% |
|
Mar 2025 (Q1)
|
$-1.39 | $-3.08 | +1.6853 | +54.80% |
Financial Statements
| Revenues | $5.07M |
| Benefits Costs and Expenses | $15.24M |
| Costs And Expenses | $15.24M |
| Nonoperating Income/Loss | $64.76K |
| Operating Expenses | $15.31M |
| Research and Development | $10.38M |
| Other Operating Expenses | $4.93M |
| Operating Income/Loss | -$10.24M |
| Income/Loss From Continuing Operations After Tax | -$10.18M |
| Income/Loss From Continuing Operations Before Tax | -$10.18M |
| Net Income/Loss | -$10.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$487.00 |
| Net Income/Loss Attributable To Parent | -$10.18M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.98 |
| Diluted Earnings Per Share | -$3.98 |
| Basic Average Shares | 2,557,377 |
| Diluted Average Shares | 2,557,377 |
| Assets | $7.45M |
| Current Assets | $7.24M |
| Noncurrent Assets | $210.01K |
| Liabilities | $4.57M |
| Current Liabilities | $4.57M |
| Accounts Payable | $3.27M |
| Other Current Liabilities | $1.30M |
| Noncurrent Liabilities | $0.00 |
| Equity | $2.88M |
| Equity Attributable To Noncontrolling Interest | -$328.97K |
| Equity Attributable To Parent | $3.21M |
| Liabilities And Equity | $7.45M |
| Net Cash Flow From Operating Activities | -$7.81M |
| Net Cash Flow From Operating Activities, Continuing | -$7.81M |
| Net Cash Flow From Investing Activities | -$931.92K |
| Net Cash Flow From Investing Activities, Continuing | -$931.92K |
| Net Cash Flow From Financing Activities | $8.74M |
| Net Cash Flow From Financing Activities, Continuing | $8.74M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$10.18M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.18M |
| Other Comprehensive Income/Loss | $0.00 |